
Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …

NHS England threatened to sue Oxford University hospitals (OUH) NHS trust after they objected to the former’s controversial decision to …

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …
A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …

NICE has published final guidance recommending heart failure drug Entresto (sacubritil/valsartan). The drug, developed by Novartis, has performed well in …

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …
The giant NHS database that could allow pharma firms to buy into patient records will now not be launched until …
Current models of healthcare are becoming unsustainable all over the world, due to people living longer with chronic diseases, and …

The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …

LinkedIn and Microsoft have signed a deal that will see the forthcoming version of Outlook incorporate feeds from the social networking platform.The …
Lilly is sponsoring a new website looking at the problems of the widespread chronic pain condition fibromyalgia. KnowFibro.com has been …
The UK has always been one of the world's leaders in drug discovery, with around half of all major medicines …
Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …